Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Anti-Acne Cream in Adolescents
NCT04118296Phase 2Completed
- Sponsor
- Sukma Skin Treatment
- Start
- Oct 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of clindamycin, dexamethasone iontophoretic patch and tretinoin in acne vulgaris, sponsored by Sukma Skin Treatment. Primary endpoint: Decrease in the severity of acne vulgaris at 1 month. Started Oct 2019; status: completed.
02
Drugs
clindamycindexamethasone iontophoretic patchtretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT04118296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04118296.